India, US working on anti-virus diagnosis

India, US working on anti-virus diagnosis


India and the US are working together on combating the deadly coronavirus and collaboration is underway in the areas of diagnostics and therapeutics of the disease, which so far has taken the lives of more than 20,000 people globally, according to the Indian envoy in Washington.

The coronavirus that first emerged in Wuhan city in China has drastically spread around the world, infecting 471,518 people and causing 21,293 deaths, according to the Johns Hopkins coronavirus tracker.

'In the present context of COVID-19 pandemic, close collaboration in the areas of diagnostics and therapeutics of the disease is underway, India's Ambassador to the US, Mr. Taranjit Singh Sandhu, said.

'India and the US have had a long-standing productive partnership in the healthcare sector, especially between the research institutions and industries of both countries, he said.

Under the existing bilateral collaboration in healthcare sector- the National Institute of Allergy and Infectious Disease in the US shared the important reagents with the Translational Health Science Technology Institute in Gurgaon.

Such cooperation is expected to play a big role in developing new therapeutics and testing reagents for the COVID-19.

In addition, India-based vendors of American companies are in touch with the Indian Council of Medical Research to engage and enhance the capabilities for COVID-19 test in India.

'The US will work shoulder to shoulder with India to combat the COVID19 outbreak. Together, we can safeguard our citizens and people everywhere, the Acting Assistant Secretary of State for South and Central Asia,Ms. Alice G Wells, said.

The US, she said, stands united with India and echoes the Prime Minister, Mr. Narendra Modi's call to keep up their fighting spirits.

Cooperation and collaboration in the sector of coronavirus was also discussed between the two countries when the US President, Mr. Donald Trump, met Mr. Modi in New Delhi last month.

Both also hailed a bilateral Memorandum of Understanding (MOU) that seeks to promote access to high quality, safe, effective, and affordable medications for US and Indian consumers.